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Abstract
Background—There is a growing recognition that individuals at clinical high risk need 
intervention for functional impairments, along with emerging psychosis, as the majority of clinical 
high risk (CHR) individuals show persistent deficits in social and role functioning regardless of 
transition to psychosis. Recent studies have demonstrated reduced reading ability as a potential 
cause of functional disability in schizophrenia, related to underlying deficits in generation of 
mismatch negativity (MMN). The present study extends these findings to subjects at CHR.
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Methods—The sample consisted of 34 CHR individuals and 33 healthy comparisons subjects 
(CNTLs) from the Recognition and Prevention (RAP) Program at the Zucker Hillside Hospital in 
New York. At baseline, reading measures were collected, along with MMN to pitch, duration, and 
intensity deviants, and measures of neurocognition, and social and role (academic/work) 
functioning.
Results—CHR subjects showed impairments in reading ability, neurocognition, and MMN 
generation, relative to CNTLs. Lower-amplitude MMN responses were correlated with worse 
reading ability, slower processing speed, and poorer social and role functioning. However, when 
entered into a simultaneous regression, only reduced responses to deviance in sound duration and 
volume predicted poor social and role functioning, respectively.
Conclusions—Deficits in reading ability exist even prior to illness onset in schizophrenia and 
may represent a decline in performance from prior abilities. As in schizophrenia, deficits are 
related to impaired MMN generation, suggesting specific contributions of sensory-level 
impairment to neurocognitive processes related to social and role function.
Keywords
Early Intervention; social functioning; clinical high risk; mismatch negativity; reading
1. Introduction
Schizophrenia is a severe mental disorder associated with significant disruptions in 
functioning. Impairments in social and occupational functioning reduce independence, limit 
educational attainment, and decrease quality of life(Green, 2006; Harvey et al., 2012), 
placing a substantial burden on patients, family members, friends and wider society(Awad 
and Voruganti, 2008; Knapp et al., 2004). Given that functional impairments in 
schizophrenia are rooted early in development, pre-illness social problems and school 
difficulties can provide a pivotal pathway to understanding the determinants of long-term 
disability. Recent research in schizophrenia has, therefore, focused on the detection of 
individuals at clinical high-risk (CHR) for developing the illness, with the ultimate goal of 
permitting focused intervention to prevent both conversion to psychosis and functional 
disability.
In established schizophrenia, several factors including neurocognition, negative symptoms, 
and social cognition are strongly connected to everyday functioning. In addition, over recent 
years there has been increasing appreciation of the importance of impaired sensory 
processing. For example, amplitudes of the auditory mismatch negativity (MMN) are 
strongly associated with work, community, and independent functioning both in patients 
with schizophrenia (Kawakubo and Kasai, 2006; Kim et al., 2014; Lee et al., 2014; Light 
and Braff, 2005a, b; Wynn et al., 2010) and first-episode psychosis (Friedman et al., 2012). 
The MMN is an auditory event-related potential (ERP) that reflects deviance-detection 
within the primary auditory cortex(Light and Näätänen, 2013; Wible et al., 2001). MMN 
amplitude reductions in schizophrenia were first demonstrated over 20 years ago (Javitt et 
al., 1993; Shelley et al., 1991) and were tied to impaired neurotransmission at N-methyl-D-
aspartate (NMDA) receptors(Javitt, 2009; 1996; Umbricht et al., 2000). Since then, 
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impairments have been replicated multiple times, with patients showing deficits of 
approximately 1 standard deviation (SD) across a range of deviant types(Todd et al., 2008; 
Umbricht and Krljes, 2005). Deficits in reading ability have also been increasingly 
documented over recent years (Martinez et al., 2012; Revheim et al., 2006; Whitford et al., 
2013). In a recent study in patients with schizophrenia, reading ability deficits were related 
with impaired MMN generation(Revheim et al., 2014), suggesting that deficits in early 
auditory processing may cascade up to produce impairments in higher-order abilities that are 
in turn linked to functioning in the environment.
To date, studies of sensory function in individuals at CHR have focused primarily on MMN 
from the vantage of transition to schizophrenia. Such studies have demonstrated consistent 
reductions of MMN in CHR individuals, albeit of smaller magnitude (typically 0.6-0.8 SDs 
vs. controls) than those observed in schizophrenia(Atkinson et al., 2012; Bodatsch et al., 
2011; Higuchi et al., 2013; Jahshan et al., 2012; Perez et al., 2013; Shaikh et al., 2012; Solis-
Vivanco et al., 2014). In addition, reductions in MMN amplitudes significantly predict 
conversion to psychosis among CHR individuals(Atkinson et al., 2012; Bodatsch et al., 
2011; Higuchi et al., 2013; Perez et al., 2013; Shaikh et al., 2012). However, a relationship 
between MMN and functioning in this vulnerable population has remained relatively 
unexplored.
Given that the antecedents of functional disability associated with schizophrenia are present 
years prior to the onset of the illness, adolescents and young adults at CHR may provide a 
timely window for investigating the contributions of early cortical processing to social and 
role functioning. Although prior MMN studies in CHR individuals have focused primarily 
on predictions of conversion to psychosis, the present study focuses as well on early sensory 
contributions to social and role functioning within the CHR population. In recent studies 
(Carrión et al., 2011; Meyer et al., 2014; Olvet et al., 2013), we have demonstrated 
significant social and role (i.e., work/academic) functioning impairments in individuals 
meeting CHR criteria. Furthermore, patients showed neurocognitive impairments that were 
highly predictive of impaired social and role functioning. Moreover, initial CHR 
classification is associated with persistent and long-standing functional difficulties 
independent of emerging psychotic symptoms (Carrión et al., 2013), suggesting that 
functional impairments may be viewed as an important component of the CHR state 
irrespective of ultimate conversion status. The present study was designed to replicate and 
extend these investigations by utilizing a neurophysiological biomarker of early auditory 
cortical function, along with standard neuropsychological measures, to further examine 
pathways to impaired functioning in CHR individuals. In addition, given recent reports of 
impaired reading ability in schizophrenia, the present study includes measures of reading 
ability. Passage reading is a skill that comes into play in a wide set of circumstances and is 
critical for academic success(Herbers et al., 2012). Passage reading, in contrast to reading 
single words, requires the manipulation of visual symbols into smaller speech sounds and 
depends on the detection of rapidly changing auditory stimuli. Although reading deficits 
have recently been reported in a limited sample of CHR subjects(Revheim et al., 2014), their 
relationship with underlying sensory impairments and functioning remains to be determined.
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2. Methods and Materials
2.1 Participants
Thirty-four subjects (age range, 12-22) met Clinical High-Risk, Positive (CHR+) criteria 
based on the presence of one or more moderate, moderately severe, or severe (scores of 3, 4, 
or 5) Scale of Prodromal Symptoms rated (scale of 0-6) attenuated positive 
symptoms(SOPS(Miller et al., 2003; 2002; 1999). Referrals to the RAP Program were made 
by affiliated outpatient and inpatient psychiatry departments, local mental health providers, 
school psychologists or counselors, or were self-referred.
Thirty-three healthy comparison subjects (CNTLs) were also enrolled and recruited through 
announcements in local newspapers and within the medical center during the same time 
period as the patients. Inclusion criteria were a baseline age between 12-25 years. Exclusion 
criteria for all participants included: (1) Schizophrenia-spectrum diagnosis(Orvaschel and 
Puig-Antich, 1994); (2) Non-English speaking; (3) History of neurological disorder; (4) 
IQ<70; (5) Healthy controls with a first-degree relative with a diagnosed Axis I psychotic 
disorder were also excluded.
This cross-sectional report includes a subsample of CHR+ participants enrolled in the larger 
second phase of the Recognition and Prevention (RAP) Program (2006-2012, total N=139), 
an NIMH funded (2000-2012) longitudinal investigation. This subsample was recruited from 
all CHR+ subjects that consecutively entered the RAP Program from 2010-2012 who were 
willing to participate in the ERP protocol. Written informed consent (≥18 years-old) or 
assent (<18) with consent from parents was obtained. The research protocol was approved 
by the Institutional Review Board at the North Shore-LIJ Health System.
2.2 Measures
Prodromal symptoms were assessed by the Structured Interview for Prodromal Syndromes 
(SIPS) and the companion SOPS (Miller et al., 2003; 2002; 1999). Social and role 
functioning was assessed using the GF:Social and GF:Role scales(Cornblatt et al., 2007). 
The GF:Social scale assesses peer relationships, peer conflict, age-appropriate intimate 
relationships, and involvement with family members. The GF:Role scale rates performance 
and amount of support needed in one’s specific role (i.e., school, work).
Reading ability was assessed with the Gray Oral Reading Test (GORT-4, (Wiederholt and 
Bryant, 2001), Comprehensive Test of Phonological Processing (CTOPP, (Wagner, 1999) 
and Wide Range Achievement Test-3 (WRAT-3, (Wilkinson, 1993). The GORT-4 Overall 
Reading Quotient (ORQ, M=100, S.D.=15) measured overall reading ability and subscale 
scores (M=10, S.D.=3) measure Rate (time taken to read a story), Accuracy (correct 
pronunciation), Fluency (Rate+Accuracy), and Comprehension (accuracy on multiple-choice 
questions). The CTOPP Phonological Awareness Composite Score (PACS) and Alternate 
PACS (APACS) measured phonological processing abilities(Revheim et al., 2006). The 
WRAT-3 Reading subtest measured single-word reading skills. The MATRICS Consensus 
Cognitive Battery (MCCB, (Green and Nuechterlein, 2004; Green et al., 2004) assessed 
neurocognitive performance in six domains: Processing Speed, Attention/Vigilance, 
Working Memory, Verbal Learning, Visual Learning, and Reasoning/Problem Solving. 
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Estimated full-scale IQ scores were derived from the Vocabulary and Block Design 
subscales of the WISC-III(Wechsler, 1991) for subjects<16 years old and WAIS-
R(Wechsler, 1981) for subjects≥16 years old.
2.3 Auditory Stimuli Presentation
Stimulus parameters were based on a previous report (Friedman et al., 2012). Sound stimuli 
were presented binaurally through foam insert headphones (ER-1, Etymotic, Illinois, USA) 
in a fixed order at stimulus onset asynchronies of 500-505ms using stimulus delivery 
software (Presentation, Neurobehavioral Systems, California, USA). Sound stimuli were a 
standard harmonic tone (p=.67, 85dB, 100ms duration, 5ms rise and fall time, overlapping 
500, 1000, and 1500Hz sinusoids). Deviant tones (p=.11 for each) included a frequency 
(three superimposed sinusoids at 450, 900 and 1650Hz), intensity (75dB), and duration 
deviant (150ms). Stimuli occurred in a fixed order (2 standards, 1 deviant). Deviant stimuli 
were also presented in a fixed order (duration, intensity, and frequency). Auditory stimuli 
were presented simultaneously with a visual distractor task in which subjects were asked to 
attend to a sequence of visual stimuli presented at central fixation and respond to a 
designated target stimulus that occurred on 11% of trials. Responses to visual stimuli were 
not analyzed as part of the present report. Auditory and visual sequences were uncorrelated 
and timed to prevent stimulus overlap.
2.4 EEG Recording and Analysis
EEG activity was recorded with a BioSemi Active-Two system (Biosemi Instrumentations, 
Amsterdam, Netherlands) from 32 pin-type active Ag/AgCl electrodes mounted in an elastic 
cap according to the international 10–20 system. Flat-type active electrodes were attached to 
the nose, left and right mastoids, and above and below the left eye (VEOG) and at the outer 
canthi of both eyes (HEOG). Additional pin-type active (CMS-common mode sense) and 
passive (DRL-driven right leg) electrodes were used to comprise a feedback loop for 
amplifier reference. EEG and EOG were recorded continuously with a sampling frequency 
of 1024Hz (band-pass .16–100Hz).
Offline data processing was performed blind to group membership with Brain Vision 
Analyzer 2 (BrainProducts, Gilching, Germany). Epochs were 500ms in duration (100ms 
pre- to 400ms post-stimulus onset). Gratton’s eye-movement correction algorithm reduced 
ocular artifacts.(Gratton et al., 1983) Trials with excessive eye or body movement (±75 μV) 
were excluded. On average, 3.1% of all trials were rejected for controls and 3.4% for CHR+ 
subjects. Grand-average ERPs to each trial type were created off-line by averaging the 
subject-averaged ERPs. The EEG signals were referenced to linked mastoids (average signal 
of electrodes placed over both mastoid bones), filtered (1-20Hz bandpass, zerophase shift, 
24 dB/octave slope and 60Hz notch filter) and baseline corrected (100ms pre-stimulus 
interval). The MMN was obtained by subtracting the standard from the deviant ERP. 
Latency windows were indentified based on visual inspection of the ERP waveforms and in 
accordance with previous research(Friedman et al., 2012). Peak amplitudes (±12.5ms 
surrounding peak) of MMN components were measured across 10 fronto-central sites (Fz, 
F3, F4, F7, F8, Cz, C3, C4, CP1, CP2) within the following post-stimulus time windows: 
110–170ms for frequency, 140-210ms for intensity, and 160–260ms for duration MMN.
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2.5 Statistical Analyses
All analyses were conducted using SPSS 16 (SPSS Inc., Illinois, USA). Demographic and 
clinical characteristics were compared with Student’s T-tests for continuous variables or 
Pearson Chi-Square tests for categorical variables (Two-tailed, P<.05). Reading ability and 
neurocognitive scores were evaluated with analysis of variance (ANOVA). Repeated 
measures ANOVA (RM-ANOVA) was also used to evaluate differences in the peak 
amplitudes of the MMN components, with group (CNTL, CHR+) as a between-subjects 
factor and deviant type (frequency, intensity, duration) as a within-subject factor.
Bivariate and partial correlation coefficients (r) among ERPs, reading ability and 
functioning were determined by multiple linear regressions. Multivariable linear regression 
models were constructed with backward (stepwise) inclusion (p<.05) with social and role 
functioning as dependent variables, and MMN amplitudes and reading measures (GORT 
ORQ, CTOPP, WRAT-3 reading scores) entered simultaneously as independent variables, 
adjusted for diagnostic group, neurocognitive performance.
3. Results
As shown in Table 1, the CNTL and CHR+ groups did not differ significantly on age, 
gender, handedness, race, or ethnicity. There was no difference in IQ, however, CNTLs had 
higher education levels. In addition, subjects at CHR+ demonstrated lower social and role 
functioning scores on the GF scales, along with higher positive, negative, disorganized, and 
general symptom levels when compared to CNTLs.
At the time of testing, a majority of CHR+ subjects (52.9%) were not receiving any 
medication. The remaining CHR subjects were receiving atypical antipsychotics (23.5%) 
and antidepressants (29.4%). Medication type or status did not account for any differences 
on any ERP component (p>.05) reported in this article.
3.1 Reading Ability and Neurocognitive Performance
CHR+ subjects and controls did not differ in estimated premorbid (single-word) reading 
ability as reflected in WRAT-3 (see Table 2). In contrast, CHR+ patients showed passage 
reading impairments with lower scores on the GORT-ORQ (p<.05), that persisted even 
when adjusting for WRAT-3 reading performance (F1,64=3.92, p=.05). When divided in 
subdomains, reading impairments as measured by the ORQ were primarily driven by 
reductions in fluency (p<.05), not comprehension (p=.29). CHR+ subjects also showed 
significant neurocognitive impairments relative to CNTLs in the domains of processing 
speed, working memory, visual learning, and verbal learning (p<.01), although other 
neurocognitive domains were not significantly affected. CHR+ subjects and CNTLs showed 
similar phonological processing as there were no significant differences on the CTOPP 
PACS (p=.92) or APACS (p=.20).
3.2 Auditory MMN Analyses
Figure 1 shows grand-averaged waveforms and 2D topographic maps for frequency, 
intensity, and duration MMN in the CNTL and CHR+ groups. Relative to CNTLs, the CHR
Carrión et al. Page 6
Schizophr Res. Author manuscript; available in PMC 2016 May 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
+ group showed a reduced MMN across all the deviant types. RM-ANOVA of MMN peak 
amplitudes indicated a significant main effect of group (F1,65=11.75, p=0.001), but a non-
significant main effect of deviant type (F2,64=2.40, p=0.10) or group × deviant type 
interaction (F2,64=0.38, p=0.68) as the degree of differences was similar across the deviant 
types. As shown in Table 3, there was a clear reduction in frequency (d=0.56), intensity 
(d=0.65), duration (d=0.68) MMN amplitudes in CHR+ subjects relative to CNTLs (see 
Table S1 for peak amplitudes at individual electrode sites). A RM-ANOVA of MMN 
latency indicated a difference in peak latency between deviant types (F2,64=101.66, p<0.001, 
ε=.89), with Frequency<Intensity<Duration, but no latency differences between groups 
(F2,64=1.56, df=1,63, p=.217) or group × deviant type interaction (F2,64=1.76, p=0.18).
3.3 Relationships between Auditory MMN, Reading Ability, and Functioning
Lower social functioning was significantly correlated with reduced frequency (r=−.22, p=.
03), intensity (r=−.30, p=.01), and duration (r=−.44, p<.001) MMN amplitudes in addition 
to lower processing speed (r=.35, p<.001), verbal learning (r=.21, p=.02), and GORT-ORQ 
(r=.23, p=.03) scores (see Table 4). However, when entered into a stepwise linear 
regression, only lower duration MMN amplitudes remained within the model (F2,64=51.11, 
β=−.181, p=.03, Adjusted R2=.60). Furthermore, this correlation remained significant, even 
after accounting for diagnostic group and neurocognitive performance (Partial r=−.26, p=.
03).
Similarly, lower role functioning correlated significantly with lower GORT-ORQ (r=.25, 
p=.03) and processing speed (r=.26, p=.02) scores, and reduced duration MMN (r=−.27, p=.
02) and intensity MMN (r=−.37, p<.01) amplitudes (see Figure 2). When entered into a 
stepwise regression, only intensity MMN reached significance (F2,64=16.62, β=−.219, p=.
04, Adjusted R2=.32). A significant correlation was observed as well between GORT-ORQ 
scores and Intensity MMN (r=−.21, p=.04).
4. Discussion
Consistent with previous reports, the current study found significant MMN reductions in 
subjects at CHR+ across three different forms of auditory deviance. CHR+ subjects also 
showed significant impairments in social and role functioning, consistent with studies from 
our group (Carrión et al., 2011; 2013; Cornblatt et al., 2012) and others (Addington et al., 
2011; Lin et al., 2011; Niendam et al., 2006; Velthorst et al., 2013). Furthermore, beyond 
replicating previous reports on MMN reductions in CHR+ subjects, our study found 
significant relationships between MMN amplitudes and both social and role functioning, 
over and above the contributions of previously described neurocognitive impairments. 
Overall, these findings extend recent studies with adult patients demonstrating a link 
between MMN amplitudes and functioning, and implicate emerging sensory processing 
deficits as prevention targets for functional impairments prior to the onset of psychosis.
In addition to showing MMN deficits, CHR+ subjects showed impairments in reading 
ability that appear to represent a decline in ability from premorbid levels, as reflected in 
single-word (WRAT-3) reading scores. Consistent with the developmental dyslexia 
literature(Kujala et al., 2006; Lovio et al., 2012) as well as a prior schizophrenia 
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study(Revheim et al., 2014), reading deficits were associated with MMN reductions, 
suggesting sensory contributions. Moreover, reading deficits in turn were associated with 
impaired role functioning, suggesting that they may represent an important target of 
intervention. In one prior CHR study(Revheim et al., 2014), isolated deficits were observed 
in rate, but not accuracy, and were somewhat less severe than in the present sample. In 
established schizophrenia, deficits were present in both reading fluency and 
comprehension(Revheim et al., 2006; 2014), suggesting a potential progression with reduced 
fluency in reading in CHR patients leading to reduced time spent in reading activities, and 
thus potential atrophy of abilities. Similarly, in established schizophrenia, deficits were also 
observed in phonological processing, which represents the ability to “sound out” novel 
words and is a critical component of reading. Despite the MMN deficits, CHR+ subjects did 
not show the phonological processing deficits seen in schizophrenia. The relative 
preservation of phonological processing may reflect the lesser degree of MMN deficit 
observed in CHR vs. established schizophrenia, and also supports early intervention to 
prevent further deterioration.
Overall, the present study confirms our earlier reports of social and role dysfunction in 
individuals at CHR+(Carrión et al., 2011). Processing speed and verbal learning were 
significantly correlated with social/role functioning, reinforcing the importance of cognitive 
dysfunction as a predictor of present dysfunction. Impairments in overall reading ability 
were also related to role functioning, consistent with findings in dyslexia. However, MMN 
amplitude contributed unique variance to functioning above and beyond neurocognitive 
performance, suggesting additional contributions of early sensory dysfunction. Previous 
studies in CHR subjects have generally not found significant relationships between MMN 
amplitudes and functioning. However, most studies to date have relied on global functioning 
measures that are confounded with symptoms (e.g., GAF), rather than measures more 
directly related to social and role functioning.
Our findings need to be viewed in the context of certain limitations. First, the potential 
impact of medication treatment on the ERP responses should be acknowledged as half the 
sample was receiving some type of psychotropic medication. However, there was no 
significant relationship between medication treatment and ERP responses. Second, our 
cross-sectional baseline data does not allow us to determine whether MMN deficits are 
predictors of long-term functional difficulties in CHR subjects. Longitudinal studies are 
needed to determine the relationship between MMN deficits, long-term functioning, and the 
transition to full-blown psychosis. Nevertheless, given recent reports of long-term functional 
impairments in CHR subjects regardless of transition to psychosis (Addington et al., 2011), 
our findings highlight the importance of early intervention as basic auditory processing 
impairments may impact baseline functioning.
Taken together, our findings demonstrate a relationship between early auditory processing 
and functioning in the stages leading up to illness and provide potential pathways by which 
underlying biology may contribute to present dysfunction within the population meeting 
symptomatic CHR criteria. Regardless of transition status, CHR individuals are 
experiencing significant current impairments in functioning, neurocognition, and reading 
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ability that require identification and intervention in order to limit long-term functional 
disability.
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Figure 1. 
Mismatch negativity for Frequency (Top), Intensity (Middle), and Duration (Bottom) 
deviants. (A) Grand averaged ERPs elicited by CHR and healthy comparison subjects at 
three representative electrode sites (Fz, F3, and F4 re-referenced to linked mastoids). CHR 
and Healthy comparison subjects are shown in pink and blue, respectively. All waveforms 
are drawn on the same voltage scale (±5μV) as shown on the bottom plots. (B) Topography 
maps depicting the scalp distribution for the MMN (peak amplitude, ±12.5ms) for each 
deviant type for healthy comparison (left) and CHR subjects (right). All maps are drawn on 
the same voltage scale (±5μV) as shown in the legend.
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Figure 2. 
Correlations between MMN amplitudes and social (left) and role (right) functioning across 
subjects at CHR and healthy comparison subjects. The correlations were significant across 
diagnostic groups (Duration MMN vs. Social functioning, r=−.44, p<.001; Intensity MMN 
vs. Role functioning, r=−.38, p<.01) and remained significant even after accounting for 
diagnostic group, neurocognitive performance, and WRAT-3 reading scores (Duration 
MMN vs. Social functioning, r=−.26, p=.03; Intensity MMN vs. Role functioning, r=−.25, 
p=.04).
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